Drug Testing And Analysis 2012-12-01

Investigations on carbon isotope ratios and concentrations of urinary formestane.

Thomas Piper, Gregor Fusshöller, Caroline Emery, Wilhelm Schänzer, Martial Saugy

Index: Drug Test. Anal. 4(12) , 942-50, (2012)

Full Text: HTML

Abstract

The aromatase inhibitor formestane (4-hydroxy-androst-4-ene-3,17-dione, F) is prohibited in sports by the World Anti-Doping Agency (WADA). F possesses only weak androgenic properties and is presumed to be employed in order to suppress estrogen production during the illicit intake of anabolic steroids by athletes. Former studies additionally showed that F is an endogenous steroid produced in low amounts. According to the regulations of WADA, urinary concentrations above 100 ng/ml are assumed to be due to ingestion of F. To distinguish between endogenous or exogenous sources of urinary F, isotope ratio mass spectrometry (IRMS) is the method of choice. Therefore, a method to determine the carbon isotope ratio (CIR) of F in urine samples was developed and validated. Routine samples (n = 42) showing concentrations of F above 5 ng/ml were investigated and enabled elucidation of the CIR of endogenous F and subsequent the calculation of a reference limit. A reference population encompassing n = 90 males and females was investigated regarding endogenous concentrations of F. An excretion study with one male volunteer was conducted to test and validate the developed method and to identify possible impact of F administration on other endogenous steroids. By CIR determination of F it is clearly possible to elucidate its endogenous or exogenous source. Taking into account the CIR of other target analytes like testosterone, a differentiation between F and androstenedione intake is possible. In 2011, the first exogenous F below the WADA threshold could be detected by means of the developed IRMS method.Copyright © 2012 John Wiley & Sons, Ltd.


Related Compounds

Related Articles:

Screening estrogenic activities of chemicals or mixtures in vivo using transgenic (cyp19a1b-GFP) zebrafish embryos.

2012-01-01

[PLoS ONE 7 , e36069, (2012)]

Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells.

2010-07-01

[Cancer Sci. 101 , 1661-9, (2010)]

The effects of aromatase inhibitors and selective estrogen receptor modulators on eye development in the zebrafish (Danio rerio).

2007-10-01

[Curr. Eye Res. 32(10) , 819-27, (2007)]

Coadministration of the aromatase inhibitor formestane and an isopropanolic extract of black cohosh in a rat model of chemically induced mammary carcinoma.

2007-04-01

[Planta Med. 73(4) , 318-22, (2007)]

The role of estrogen in the developmental appearance of sensory-motor behaviors in the zebrafish (Danio rerio): The characterization of the “listless” model

2008-01-01

[Brain Res. 1222 , 118-28, (2008)]

More Articles...